Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)
Clinical trial NCT03767543 · COMPLETED
Trial details
- NCT number
- NCT03767543
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-11
- Primary completion
- 2020-10-23
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.